Skip to content

Crestview Partners IV GP, L.P.

Follow

13F filer, CIK 1818687, NEW YORK, NY

Crestview Partners IV GP, L.P. reported $484,924,440 across 2 holdings for the quarter ended 2026-06-30, in a 13F-HR filed 2026-08-13.

Filed (acceptance time not in the bulk data set), ingested 13F-HR 0000950142-26-002335

Period
2026-06-30
Reported value
$485M
Holdings
2
Top 10 weight
100%
New
0
Sold out
0

Holdings, Q2 2026

Share positions as resolved from 13F-HR 0000950142-26-002335, largest first. % of portfolio is the value over $484,924,440, the sum of the share positions whose value is usable for ratios (method).

SecurityHistorySharesValue% of portfolioChangeLatest eventTimeline
PRSUPURSUIT ATTRACTIONS AND HOSPQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: 19,093 shares; 2024Q4: 6,693,327 shares; 2025Q1: 6,697,979 shares; 2025Q2: 6,697,979 shares; 2025Q3: 6,697,979 shares; 2025Q4: 6,697,979 shares; 2026Q1: 6,701,128 shares; 2026Q2: 6,701,128 shares 6,701,128$375M77.34%0Timeline
PLGOPELAGOS INS CAP LTDQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: 4,707,902 shares; 2024Q4: 4,707,902 shares; 2025Q1: 4,511,799 shares; 2025Q2: 4,511,799 shares; 2025Q3: 4,511,799 shares; 2025Q4: 4,511,799 shares; 2026Q1: 4,511,799 shares; 2026Q2: 4,511,799 shares 4,511,799$110M22.66%0Timeline

How Q2 2026 was built

Available 13F filings of this filer for the quarter and their roles: the base report is the latest original or restatement, NEW HOLDINGS amendments filed after it are added (method).

FilingRoleAmendmentFiledAcceptedIngested
13F-HR 0000950142-26-002335 base2026-08-13acceptance time not in the bulk data set

Filings

Every filing of this filer: 13F reports and notices, the 13D and 13G it filed or is a reporting person of, and Forms 3, 4 and 5 it reported as an owner.

FilingSubjectFiledAcceptedIngested
13F-HR 0000950142-26-002335 Quarter ended 2026-06-302026-08-13acceptance time not in the bulk data set
13F-HR 0000950142-26-001388 Quarter ended 2026-03-312026-05-14acceptance time not in the bulk data set
13F-HR 0000950142-26-000377 Quarter ended 2025-12-312026-02-13acceptance time not in the bulk data set
13F-HR 0000950142-25-002973 Quarter ended 2025-09-302025-11-14acceptance time not in the bulk data set
13F-HR 0000950142-25-002142 Quarter ended 2025-06-302025-08-12acceptance time not in the bulk data set
13F-HR 0000950142-25-001368 Quarter ended 2025-03-312025-05-14acceptance time not in the bulk data set
13F-HR 0000950142-25-000381 Quarter ended 2024-12-312025-02-14acceptance time not in the bulk data set
13F-HR 0000950142-24-002739 Quarter ended 2024-09-302024-11-12acceptance time not in the bulk data set
13F-HR 0000950103-24-012105 Quarter ended 2024-06-302024-08-13acceptance time not in the bulk data set
13F-HR 0000950103-24-006561 Quarter ended 2024-03-312024-05-10acceptance time not in the bulk data set
13F-HR 0000950103-24-002132 Quarter ended 2023-12-312024-02-13acceptance time not in the bulk data set
13F-HR 0000950103-23-016236 Quarter ended 2023-09-302023-11-14acceptance time not in the bulk data set
13F-HR 0000950103-23-011925 Quarter ended 2023-06-302023-08-11acceptance time not in the bulk data set
13F-HR/A 0000950103-23-007120 Quarter ended 2022-12-312023-05-10acceptance time not in the bulk data set
13F-HR 0000950103-23-007121 Quarter ended 2023-03-312023-05-10acceptance time not in the bulk data set
13F-HR 0000950103-23-002095 Quarter ended 2022-12-312023-02-09acceptance time not in the bulk data set
13F-HR 0000950103-22-019408 Quarter ended 2022-09-302022-11-09acceptance time not in the bulk data set
13F-HR 0000950103-22-013841 Quarter ended 2022-06-302022-08-09acceptance time not in the bulk data set
13F-HR 0000950103-22-007856 Quarter ended 2022-03-312022-05-04acceptance time not in the bulk data set
13F-HR 0000950103-22-002296 Quarter ended 2021-12-312022-02-09acceptance time not in the bulk data set
13F-HR 0000950103-21-017187 Quarter ended 2021-09-302021-11-02acceptance time not in the bulk data set